Zoll agrees $538m deal to buy sleep apnoea specialist ItamarItamar Medical was on the acquisition trail itself earlier this year, buying Spry Health to extend its sleep Share XZoll agrees $538m deal to buy sleep apnoea specialist Itamarhttps://pharmaphorum.com/news/zoll-agrees-538m-deal-to-buy-sleep-apnoea-specialist-itamar/
Lilly adds to pain pipeline with Asahi Kasei licensing dealUS drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has Share XLilly adds to pain pipeline with Asahi Kasei licensing dealhttps://pharmaphorum.com/news/lilly-adds-to-pain-pipeline-with-asahi-kasei-licensing-deal/
